palm oil: health and nutritional benefits

26
Page 1 Palm Oil: Palm Oil: ...Health and Nutritional Benefits ...Health and Nutritional Benefits Pramod Khosla, PhD Associate Professor, Dept. of Nutrition & Food Science, Wayne State University, Detroit, MI 48202 Chronic Disease Cardiovascular disease Cancer Diabetes Osteoporosis Hypertension Exercise Fat Quality Low calories: More fiber, grains, vegs. More fruits Lower sodium Increased calcium Control CHO & energy intake Cognitive dec ??????????????

Upload: others

Post on 01-Nov-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1

Palm Oil:Palm Oil:...Health and Nutritional Benefits...Health and Nutritional Benefits

Pramod Khosla, PhD

Associate Professor,

Dept. of Nutrition & Food Science,

Wayne State University,

Detroit, MI 48202

Chronic Disease

Cardiovasculardisease

Cancer

Diabetes

Osteoporosis

Hypertension

ExerciseFat Quality

Low calories: More fiber, grains, vegs. More fruits

Lower sodium

Increased calcium

Control CHO &energy intake

Cognitive dec ??????????????

Page 2

� No smoking

� Maintain a healthy body weight

� Low to moderate intensity exercise 30-45 mins/day

Diet and Lifestyle changesDiet and Lifestyle changes� Fat quality

� Protein quality

� Fiber

� Antioxidants

� Phytochemicals

� Carbohydrate type

� Alcohol

DIETARY DIETARY FAT

Per Capita Fat Consumption Per Capita Fat Consumption -- g/dayg/day

0

10

20

30

40

50

60

70

80

90

100

Afr

ica

Asia

CA

mer

ica

SAm

eric

a

REuro

pe

Oce

ania

NA

mer

ica

EU

15

Source : FAO websiteSource : FAO website

WHO recommendationWHO recommendation

Page 3

RISK FACTORS FOR CHD RISK FACTORS FOR CHD RISK FACTORS FOR CHD RISK FACTORS FOR CHD

� Gender

� Increasing age

� Genetics: Family history of CHD

� High TC, LDL-C

� Low HDL-C

� Smoking

� Diabetes

� Obesity

DIET

Fat quality

Protein quality

Fiber

Antioxidants

Phytochemicals

Carbohydrate type

Alcohol

Dietary fat composition: by fatty acid classesDietary fat composition: by fatty acid classes

0

10

20

30

40

50

60

70

80

90

100

Fatty Acid Classes ,%

SFA

AAD34%en15:12:7P/S 0.4

Coco PKO MilkF CoButt Tallow Pstear Palm POlein Lard Chick Olive hiOsun Canola Soyb Corn Saff

TFA

MUFA

PUFA

PUFA

MUFA

SFA

Page 4

What about trans fatty acids?What about trans fatty acids?

•Unsaturated fatty acids - at least one trans double bond

•Partial hydrogenation of polyunsaturated oils - isomerization and migration of double bonds - distribution of cis and transdouble bonds (margarines, shortenings, salad & cooking oils)

•Partial hydrogenation����tFA. Full hydrogenation ���� SFA

•Major tFA - elaidic acid (t9 - 18:1)

•Dairy and meats have t9 - 16:1 and t11 - 18:1 (vaccenic acid)

…what are the effects of fatty acid …what are the effects of fatty acid classes on lipoprotein cholesterol? classes on lipoprotein cholesterol?

Page 5

-0.02

0

0.02

0.04

LDL

S

cM

P

tM

0

0.02

0.04

HDL

S

cM

P

tM

-0.04-0.02

00.020.04

TC/HDL

S

cM

P

tM

Changes shown in mmol/L for LDL and HDL. Adapted from Mensink et al Am J Clin Nutr Changes shown in mmol/L for LDL and HDL. Adapted from Mensink et al Am J Clin Nutr (2003) 77: 1146(2003) 77: 1146--11551155

MUFA & PUFA best.MUFA & PUFA best.Trans worse than SFATrans worse than SFA

CHO CHO �������� FAFA

-0.06

-0.04

-0.02

0

S cM P

-0.04

-0.02

0

0.02

S S cMcM P P tFAtFA

tFA tFA �������� FAFA

Effects on the TC/HDLEffects on the TC/HDL--C ratioC ratio

Am J Clin Nutr (2003) 77: 1146Am J Clin Nutr (2003) 77: 1146--11551155 N Engl J Med (2006) 344: 1601N Engl J Med (2006) 344: 1601--16131613

Page 6

Ascherio et al, (1999 N Engl J Med 340: 1994-1998 55

TC/HDLTC/HDL--C adversely affected by the C adversely affected by the trans..trans..

Diet

a

1 2 3 4 5 6 7 8 9 10 11

TransPalmitate

0

20

40

60

80

100

120

140

-20

-10

0

10

20

% t

ran

sfer

(c.

f. c

on

trol)

16:0 Trans

p = 0.03

Khosla et al, (1997)

trans lowers HDLtrans lowers HDL--CC

trans increases TC/ HDLtrans increases TC/ HDL--C ratioC ratio

trans increases CETPtrans increases CETP

Page 7

…so what about effects on CVD? …so what about effects on CVD?

Dietary Fat intake and Risk of CHD and Type II Dietary Fat intake and Risk of CHD and Type II Diabetes (TIID) in WomenDiabetes (TIID) in Women

CHD data - Hu et al, (1997) N Engl J Med, 337: 1491-1499

Type II Diabetes data - Salmeron et al, (2001) Am J Clin Nutr 73: 1019-1026

Effects of replacing 5%en from carbohydrates with specific fatty acidsEffects of replacing 5%en from carbohydrates with specific fatty acids

Effects of replacing 2%en from carbohydrates with trans fatty acidsEffects of replacing 2%en from carbohydrates with trans fatty acids

Page 8

-30

-20

-10

0

10

20

30

40

50

60

SFA MUFA PUFA tFA

1

2

3

4

5

from Oh et al (2005) Am J Epidemiol, 161: 672-679

1.6 to 2.8% en4.1 to 7.4% en12 to 18% en

Relative risk of CHD based on quintiles of dietary fatty acid intake Relative risk of CHD based on quintiles of dietary fatty acid intake (Multivariate analyses) (Multivariate analyses)

20 year follow20 year follow--up data from the Nurses Health Studyup data from the Nurses Health Study

Beneficial effects with PUFABeneficial effects with PUFA

Adverse effects with tFAAdverse effects with tFA

• Pooled analysis of 11 studies. 4-10 year follow-up

• Pooled RR evaluated in 344, 696 subjects (5, 249 coronary events, 2155 coronary deaths)

• Effect of 5% lower energy intake from SFA with a simultaneous higher energy intake from PUFA, carbs or MUFA is shown for coronory events and coronory deaths

Jakobsen et al , (2009) Am J Clin Nutr 89: 1425 - 1432

0

0.2

0.4

0.6

0.8

1

1.2

1.4

PUFA Carbs MUFA

Replacing SFA with different fatty acids or carbohydratesReplacing SFA with different fatty acids or carbohydrates

Page 9

• Prospective cohort study. Median 12 year follow-up

• Hazard Ratio evaluated in 53, 644 subjects [1, 943 cases of incident myocardial infarction (MI)]

• For a 5% lower energy intake from SFA with a simultaneous higher energy intake from carbs with different GI values

• Singificant association with high GI carbs

Exchanging 5% calories from SFA with Exchanging 5% calories from SFA with carbscarbs of different GI valuesof different GI values

Jakobsen et al , (2009) Am J Clin Nutr 89: 1425 - 1432

MichaMicha and and MozaffarianMozaffarian, (2010) Lipids. 45: 893, (2010) Lipids. 45: 893--905905

Predicted effects are based on changes in the TC:HDL-C ratio

Evidence from a meta-analysis of eight randomized controlled trials

Evidence for observed relationships of usual dietary habits with CHD events comes from a

pooled analysis of 11 prospective cohort studies.

Effects on CHD risk of consuming PUFA, carbs , or MUFA in place of SFA

Page 10

MetaMeta--analysis of 21 prospective epidemiologic studies showed no analysis of 21 prospective epidemiologic studies showed no significant evidence for concluding SFA are associated with increased significant evidence for concluding SFA are associated with increased CHD riskCHD risk

• 5-23 year follow-up

• Pooled RR evaluated in 347, 747 subjects (11, 006 developed CHD or stroke)

• SFA intake was not associated with

CHD (Pooled RR – 1.07; 95% CI 0.96 – 1.19, p=0.22)

Stroke (Pooled RR - 0.81; 95% CI 0.62 – 1.05, p=0.11)

CVD – (Pooled RR - 1.00; 95% CI 0.89 – 1.11, p=0.95)

Siri-Tarino et al , (2010 ) Am J Clin Nutr 91: 535 – 546

Association of Dietary, Circulating, and Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk:Supplement Fatty Acids With Coronary Risk:A Systematic Review and MetaA Systematic Review and Meta--analysisanalysis

Chowdhury et al, (2014) Ann Int Med 160: 398-406

Page 11

Date of download: 3/18/2014

Copyright © American College of Physicians. All rights reserved.

Figure Legend:

Dietary Fatty Acids and CHD: Summary of the EvidenceDietary Fatty Acids and CHD: Summary of the Evidence

C = Convincing evidence; P = Probable evidence; NR C = Convincing evidence; P = Probable evidence; NR –– no relation; no relation; RedRed denotes denotes increased risk while increased risk while GreenGreen denotes decreased riskdenotes decreased risk

Fatal CHD CHD events

Total Fat C-NR C-NR

TFA P C

SFA/CHO P-NR P-NR

MUFA/SFA

PUFA/SFA C C

Linoleic acid

Alpha Linolenic

n3 LCPUFA P C

Skeaff and Miller , (2009) Ann. Nutr. Metab. 55: 173Skeaff and Miller , (2009) Ann. Nutr. Metab. 55: 173--201201

Page 12

…what about individual saturated FA? …what about individual saturated FA?

Dietary fats comprised of individual fatty acids Dietary fats comprised of individual fatty acids –– especially important for SFAespecially important for SFA

0

10

20

30

40

50

60

70

80

90

100

Fatty Acid Classes

16:0

AAD34%en15:12:7P/S 0.4

Coco PKO MilkF CoaBut Tallow Pstear Palm pOle Lard Chick Olive hiOsun Canola Soyb Corn Saff

18:0

C18:1

18:2

18:3

t18:1

10:06:0+ 8:0

12:0

14:0

16:1

10/2510/25

Page 13

Effects of individual SFA on lipoprotein cholesterolEffects of individual SFA on lipoprotein cholesterol

-0.020

0.020.040.06

LDL

L

M

P

S

0

0.02

0.04

0.06

HDL

L

M

P

S

-0.04

-0.02

0

0.02

TC/HDL

L

M

P

S

Changes shown in mmol/L for LDL and HDL. Adapted from Mensink et al Am J Clin Nutr Changes shown in mmol/L for LDL and HDL. Adapted from Mensink et al Am J Clin Nutr (2003) 77: 1146(2003) 77: 1146--11551155

14:0, 16:0 no effect14:0, 16:0 no effect18:0, 12:0 beneficial18:0, 12:0 beneficial

• The global importance of palm oil

• Effects of palm oil on the ration of TC/HDL-C…

• Replacement for trans fatty acids

• Variety of carotenoids - pro Vitamin A

• Vitamin E (tocopherols and tocotrienols)

Nutritional attributes of Palm Oil and Nutritional attributes of Palm Oil and Palm Palm OleinOlein

Page 14

…the global importance of palm oil? …the global importance of palm oil?

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

Soybean

oil

Palm oil Rapeseed

oil

Sunflower

oil

Animal

Fats

Laurics Others

33.3 33.5

16.0

9.7

23.3

7.0

16.6

million

to

nne

s

Soybean40%

Palm

4%

Rapeseed

12%Sunflower10%

Coconut

4%

Others

30%

Total Area

Soybean29%

Palm 29%

Rapeseed14%

Sunflower8%

Laurics6%

Others14%

Total Vegetable Oil Output

0

0.5

1

1.5

2

2.5

3

3.5

4

SBOSunflO

RapSO

Tonnes/hectare/year

Soybean oil18%

Palm oil52%

Rapeseed oil3%

Sunflower oil8%

Animal Fats7%

Laurics8%

Others4%

Global ExportsGlobal Exports

Others

Taiwan

Nigeria

Russia

South Korea

South Africa

Turkey

Japan

Mexico

Bangladesh

Iran

Pakistan

N Africa

India

EU-27

China PR

(x

100

0

ton

Net Importers

Net Exporters

Page 15

…effects of palm oil on the ratio of TC/HDL…effects of palm oil on the ratio of TC/HDL--C? C?

Palm Olein and MUFAPalm Olein and MUFA--rich Oils exert similar effects on the ratio of rich Oils exert similar effects on the ratio of Total cholesterol to HDL cholesterol (TC/HDLTotal cholesterol to HDL cholesterol (TC/HDL--C) in human subjectsC) in human subjects

Page 16

Palm oil and blood lipid related markers Palm oil and blood lipid related markers of cardiovascular disease: a systematic of cardiovascular disease: a systematic

review and metareview and meta--analysis of dietary analysis of dietary intervention trialsintervention trials

FattoreFattore et al, , (2014) Am J. et al, , (2014) Am J. ClinClin NutrNutr. . doidoi: 10.3945/ajcn.113.081190: 10.3945/ajcn.113.081190

• 51 studies; 1526 volunteers (2/3 men); ages 16-70 y

• Studies from Australia, Canada, China, Denmark, Finland, France, India, Malaysia, Netherlands, Norway, Scotland, South Africa, Spain, Thailand, USA

• Feeding times 2 to 16 wks

• Studies in healthy volunteers who were normocholesterol-emic, hypercholesterolemic as well as n/h subjects

• Dietary fat content 28% to 53% of total calories (test fat 4% to 43% of total calories)

Synopsis of metaSynopsis of meta--analysisanalysis

Page 17

TC LDL VLDL apoB HDL ApoAI TG Lp(a) LDL / HDL

TC / HDL

Stearic I I N I I I N N I N

Lauric + Myristic

D N N N D D N N N

MUFA I I N I I N N N N N

PUFA I N N I I I N N N N

transFA N N N D I I D N N D

Effects on plasma lipoproteins of substituting various fatty acids with palm oil

I- increase, D – decrease and N – no significant change

Adpated from Fattore et al, (2014). Am J Clin Nutr 99: 1331-1350

…palm oil as a replacement for trans fat? …palm oil as a replacement for trans fat?

Page 18

……. ……. practical aspectspractical aspects

SFA vs tFA– not a realistic comparison

Look at specific fats/oils replacing

PHVO containing tFA

CHD risk based not just on changes

in plasma lipoproteins.

Report of Mozaffarian and Clarke (2009)

is of interest

Also risk assessment papers

(Barraj et al 2008, Mente et al 2009)

…so how much palm oil …so how much palm oil in the diet? in the diet?

Page 19

conservative conservative ---- based on current recommendations for based on current recommendations for restricting SFArestricting SFA----can calculate the amount of palm oil in a can calculate the amount of palm oil in a prudentprudent diet that satisfies various dietary guidelinesdiet that satisfies various dietary guidelines

Khosla (2006) J Agro Food Ind. 17: 21-23 Hayes and Khosla, Eur J Lipid Sci Tech (2007) 109: 453-464

…can readily replace trans by blending …can readily replace trans by blending palm with local vegetable oils? palm with local vegetable oils?

Page 20

Dietary fat composition: by fatty acid classesDietary fat composition: by fatty acid classes

0

10

20

30

40

50

60

70

80

90

100

SFA

AAD34%en15:12:7P/S 0.4

Coco PKO CoButt Pstear Palm Polein Olive Sun Canola Soy Corn Saff

TFA

MUFA

PUFA

““““RD””””30%en

10:10:10P/S 1.0

Dietary fat composition: by fatty acid classesDietary fat composition: by fatty acid classes

0

10

20

30

40

50

60

70

80

90

100

SFA

TFA

MUFA

PUFA

Coco PKO CoButt Pstear Palm Polein Olive PO/SBO Canola Soy Corn SaffAAD

34%en15:12:7P/S 0.4

““““RD””””30%en

10:10:10P/S 1.0

Palm/Soy 1:1 mixPalm/Soy 1:1 mix

Page 21

• The global importance of palm oil

• Effects of palm oil on the ration of TC/HDL-C…

• Replacement for trans fatty acids

• Variety of carotenoids - pro Vitamin A

• Vitamin E (tocopherols and tocotrienols)

Nutritional attributes of Palm Oil and Nutritional attributes of Palm Oil and Palm OleinPalm Olein

““““““““Vitamin AVitamin A”””””””” activity of red palm oilactivity of red palm oilRE

Per 100 g

Relative quality

(Times <red palm oil

Red Palm Oil

30,000 -

Carrots 2,000 15

Leafy Vegetables

685 44

Apricots 250 120

Tomatoes 100 300

Bananas 30 1000

Orange Juice

8 3,750

Phytoene 2.0%

Phytofluene 1.2%

Cis-β- Carotene 0.8%

β – Carotene 47.4%

α- Carotene 37.0%

Cis- α- Carotene 6.9%

ζ- Carotene 1.3%

δ - Carotene 0.6%

γ - Carotene 0.5%

Neurosporene Tr

β - Zeacarotene 0.5%

α - Zeacarotene 0.3%

Lycopene 1.5%

Numerous human studies showing efficacy Numerous human studies showing efficacy of red palm oilof red palm oil in fighting Vitamin A deficiencyin fighting Vitamin A deficiency

Page 22

…studies have adopted different methods to provide Vitamin A naturally…studies have adopted different methods to provide Vitamin A naturally

� Children fed traditional Indian sweets made with redPO

� School children fed biscuits baked with redPO

� School children given 5 – 10 mL redPO daily

� Cooking green leafy vegetables in redPO

� Also Vitamin A status improved by feeding redPO to pregnant mothers at various stages of pregnancy.

� Also lactating mothers

Numerous human studies showing efficacy of Numerous human studies showing efficacy of red palm oil red palm oil in fighting Vitamin A deficiencyin fighting Vitamin A deficiency

• The global importance of palm oil

• Effects of palm oil on the ration of TC/HDL-C…

• Replacement for trans fatty acids

• Variety of carotenoids - pro Vitamin A

• Vitamin E (tocopherols and tocotrienols)

Nutritional attributes of Palm Oil and Nutritional attributes of Palm Oil and Palm OleinPalm Olein

Page 23

• Variety of carotenoids (Vitamin A)

• Vitamin E (tocopherols and tocotrienols)

Nutritional attributes of PNutritional attributes of Palm Oil & Palm alm Oil & Palm OleinOlein

Oil Tocopherols(ppm)

αT βT γT δT

Tocotrienols(ppm)

αT3 βT3 γT3 δT3

Ppm

T+T3

Red Palm Oil 152 - - - 205 - 439 94 890

Soyabean 101 - 593 264 985

Cornoil 112 50 602 18 782

Groundnut 130 - 216 21 367

Safflower 387 - 174 240 801

Sunflower 487 - 51 8 546

Numerous in vitro studies showing efficacy of Numerous in vitro studies showing efficacy of tocotrienolstocotrienols in inhibiting in inhibiting cancer cellcancer cell proliferation proliferation and decreasingand decreasing neurodegenerationneurodegeneration. .

A pilot human breast cancer clinical trial was A pilot human breast cancer clinical trial was not definitivenot definitive

A series of studies show efficacy A series of studies show efficacy against lung cancer against lung cancer and Phase I and Phase I human studies are the next logical stephuman studies are the next logical step

Ongoing human Ongoing human stroke prevention stroke prevention trial is recruiting subjects. An earlier trial is recruiting subjects. An earlier study from our lab helped establish the dosestudy from our lab helped establish the dose

Evidence that Evidence that tooctrienolstooctrienols may lower blood lipids may lower blood lipids –– and possible and possible synergy with synergy with statinstatin drugs has been suggested??drugs has been suggested??

Recent Recent Phase I study Phase I study in dialysis patients from in dialysis patients from our laboratoryour laboratory. .

Page 24

TocotrienolTocotrienol effects on white matter lesionseffects on white matter lesions

Mean white matter lesion volume -change from baseline of tocotrienol and placebo treated groups (1 and 2 yrs)

Gopalan et al. Stroke, 2014

⬇Renal Function Dialytic Factors Co-morbidities

↓Clearance of cytokine↑of uremic toxins

BioincompatibilityVascular access

Protein catabolizers

Chronic infectionsDiabetes mellitus

Congestive heart failure

Inflammation

PEW

Anorexia

CVD

OxidativeStress

↓protein & energy↓antioxidant intake

Adapted from: Ikizler et al 2004; Libetta et al 2011

⬆ Energy expenditure

Pathophysiology of Pathophysiology of CVD in CKD/ESRDCVD in CKD/ESRD

Dyslipidemia

Delayed catabolism of TG-rich lipoprotein

↓ HDL

Page 25

Screened for eligibility(n=118)

Screened for eligibility(n=118)

Randomization(n=81)

Randomization(n=81)

Excluded (n=37)Did not met inclusion criteria

(n=30)Declined to participate (n=7)

Allocated to TRF(n=41)

Allocated to TRF(n=41)

Allocated to Placebo(n=40)

Allocated to Placebo(n=40)

Analyzed(n=37)

Analyzed(n=37)

Analyzed(n=40)

Analyzed(n=40)

Died (n=1) (Cardiac arrest)Underwent transplantation (n=1)

Excluded (catheter dysfunction) (n=1) Week 1

Week 3

1 pt c/o diarrhea – but willing to continue the study

Baseline

Week 12

Week 8

Week 12 Died (n=1) (Cardiac arrest)

Week 16

Daud et al. Vasc. Health Risk Manag, 2013

Exclusion criteria:< 3 months on HD treatment

< 18 years old

Vit. E supplement

Stay in nursing home

On interdialytic PN

Lipid changes during the course of the study

*P<0.05(P=0.07)-60

-50

-40

-30

-20

-10

0

10

20

30

Placebo TRF

Daud et al. Vasc. Health Risk Manag, 2013

*

p<0.001

*p<0.05

0

5

10

15

20

25

30

Week-8 Week-12 Week-16

Triglyceride HDL-cholesterol

Page 26

Oil Palm Oil Palm PhenolicsPhenolics –– the exciting future the exciting future

Oil palm fruit Oil palm fruit –– water soluble water soluble phenolicsphenolics -- scaled production scaled production

First First nutritionnutrition studies reported starting in 2011studies reported starting in 2011

NeuroprotectiveNeuroprotective, anti, anti--atherogenicatherogenic, anti, anti--diabetic and antidiabetic and anti--cancer cancer effectseffects

SummarySummary

Diet and Lifestyle changes – first line of defense – can have profound effect on chronic disease (prevention)

Alcohol, smoking and lack of physical activity – major drivers

Numerous dietary changes shown to be effective

Palm Oil – serves a multitude of nutritional needs

Supply of palm oil makes it the important player globally and is an important factor in global food security

Fatty acid profile of palm eliminates need for hydrogenation

Minor components (antioxidant/phytochemicals) help alleviate micronutrient deficiencies using food-based approach AND show promise for preventative route in certain chronic disease

Additional details: J. Am. Coll. Nutr. (2010), 29 (3S) 237-340